コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 surprisingly, transcriptional activation by interferon regulatory factors.
2 on and was associated with downregulation of interferon regulatory factor 1 (IRF-1) and decreased lev
3 ion and activity of the transcription factor interferon regulatory factor 1 (IRF-1) and expression of
4 ving inhibition of the transcription factors interferon regulatory factor 1 (IRF-1) and upstream stim
5 ion of type I interferon (IFN) signaling and interferon regulatory factor 1 (IRF-1) expression is req
8 ion and joint-associated swelling.IMPORTANCE Interferon regulatory factor 1 (IRF-1) is a transcriptio
11 Here we report that the transcription factor interferon regulatory factor 1 (IRF-1) is required for c
12 growth factor beta (TGF-beta) signaling, and interferon regulatory factor 1 (IRF-1) transactivation.
14 of viral double-stranded RNA, depends on the interferon regulatory factor 1 (IRF1) and IRF2 transcrip
15 b which has full enhancer activity and binds interferon regulatory factor 1 (IRF1) and nuclear factor
16 ransitioned cells are defective in inducible interferon regulatory factor 1 (IRF1) expression by occl
17 association in European Americans was at the interferon regulatory factor 1 (IRF1) locus on 5q31.1.
19 ed in the 5'-end of the STAT1-dependent gene interferon regulatory factor 1 (IRF1), but the role of t
20 is highly dynamic at the STAT1 target gene, interferon regulatory factor 1 (IRF1), suggesting that a
22 man herpesvirus 8 (HHV-8) gene product viral interferon regulatory factor 1 (vIRF-1) is targeted to m
25 immunity to dietary antigen was dependent on interferon regulatory factor 1 and dissociated from supp
26 rafficking and macrophage recruitment (e.g., interferon regulatory factor 1, CD97), adaptive immune r
28 lost its transient nature in the absence of interferon-regulatory factor 1 (IRF-1), a transcription
29 expression of the transcription factor IRF1 (interferon-regulatory factor 1), the roles of IRF1 in im
30 tory factor (IRF) family members, especially interferon regulatory factor-1 (IRF-1) and interferon re
33 y SNP (-1623A/G) modified a binding site for interferon regulatory factor-1 (IRF-1), a major interfer
36 saccharide-induced nuclear factor-kappaB and interferon regulatory factor-1 activation in RAW 264.7 m
37 nitric oxide synthase and cyclooxygenase-2, interferon regulatory factor-1, interferon-inducible pro
40 network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription fact
41 a-replication factor C3 (RFC3), FAM111A, and interferon regulatory factor 2 (IRF2)-were confirmed by
42 ess expression of the transcription cofactor interferon regulatory factor 2-binding protein 2 (IRF2BP
45 ator of interferon genes-TANK-binding kinase-interferon regulatory factor 3 (cGAS-STING-TBK1-IRF3) si
47 sponses mediated by the transcription factor interferon regulatory factor 3 (IRF-3) are often vital f
48 actors nuclear factor kappaB (NF-kappaB) and interferon regulatory factor 3 (IRF-3) at a step subsequ
49 e models, the antiviral transcription factor interferon regulatory factor 3 (IRF-3) enhances reovirus
51 n in vitro, class II transactivator (CIITA), interferon regulatory factor 3 (IRF-3), and interferon r
52 actors nuclear factor kappaB (NF-kappaB) and interferon regulatory factor 3 (IRF-3), classically indu
53 hibited poly(I.C)-induced phosphorylation of interferon regulatory factor 3 (IRF-3), which is the key
54 key proapoptotic protein in this pathway is interferon regulatory factor 3 (IRF-3), which upon activ
57 HeLa cells, EV68 inhibits poly(I.C)-induced interferon regulatory factor 3 (IRF3) activation and bet
58 (IFN-I) production through inhibition of the interferon regulatory factor 3 (IRF3) activation pathway
59 1 and -2 was required for phosphorylation of interferon regulatory factor 3 (IRF3) and accumulation o
60 sed S. pneumoniae induced phosphorylation of interferon regulatory factor 3 (IRF3) and activating tra
61 s) required for initiating the activation of interferon regulatory factor 3 (IRF3) and interferon (IF
62 stimulator 1 (IPS-1)-mediated activation of interferon regulatory factor 3 (IRF3) and NF-kappaB sign
63 ents and activation of transcription factors interferon regulatory factor 3 (IRF3) and NF-kappaB, STI
65 r proteins leading to activation of both the interferon regulatory factor 3 (IRF3) and nuclear factor
66 nscription via transcription factors such as interferon regulatory factor 3 (IRF3) and nuclear factor
68 phosphorylation of the transcription factor interferon regulatory factor 3 (IRF3) and subsequent exp
69 ds to activation of the transcription factor interferon regulatory factor 3 (IRF3) and subsequent tra
70 -dependent phosphorylation and activation of Interferon Regulatory Factor 3 (IRF3) and the E3 ubiquit
71 TBK1 phosphorylates the transcription factor Interferon Regulatory Factor 3 (IRF3) and the E3 ubiquit
72 then bind to a positively charged surface of interferon regulatory factor 3 (IRF3) and thereby recrui
74 ls by preventing not only phosphorylation of interferon regulatory factor 3 (IRF3) but also degradati
75 d not bind MDA5 efficiently, did not inhibit interferon regulatory factor 3 (IRF3) dimerization or IF
77 nse to viral infection by degradation of the interferon regulatory factor 3 (IRF3) has been subject o
78 of the immune signaling transcription factor interferon regulatory factor 3 (IRF3) in response to cyt
79 ndrial antiviral signaling protein (MAVS) or interferon regulatory factor 3 (IRF3) in the IFN inducti
80 on of ZAP occurs under the direct control of interferon regulatory factor 3 (IRF3) independent of int
84 y and confirmed that these miRNAs potentiate interferon regulatory factor 3 (IRF3) phosphorylation an
88 tiviral interferon antagonist which degrades interferon regulatory factor 3 (IRF3) through the protea
89 ntly phosphorylates the transcription factor interferon regulatory factor 3 (IRF3) to promote interfe
90 antagonist capable of blocking activation of interferon regulatory factor 3 (IRF3) via the retinoic a
91 sible for HIV-1 targeting and degradation of interferon regulatory factor 3 (IRF3), a central transcr
93 cells causes partial proteolytic cleavage of interferon regulatory factor 3 (IRF3), a key transcripti
94 hondrial antiviral signaling protein (MAVS), interferon regulatory factor 3 (IRF3), or Interferon-alp
95 uit TANK-binding kinase 1 (TBK1) to activate interferon regulatory factor 3 (IRF3), resulting in prod
96 E) inhibits TBK1-mediated phosphorylation of interferon regulatory factor 3 (IRF3), which is essentia
97 s alcoholic liver disease (ALD) and that the interferon regulatory factor 3 (IRF3),a transcription fa
98 rom the site of inoculation independently of interferon regulatory factor 3 (IRF3)-, IRF7-, and IFNAR
107 IFN-beta promoter when it was stimulated by interferon regulatory factor 3 (IRF3)/5D or its upstream
109 anscription factors was increased, including interferon regulatory factor 3 and 7 (IRF-3 and IRF-7) a
111 ciated with increased baseline expression of interferon regulatory factor 3 and 7 mRNAs and productio
112 l28ra(-/-)), and mice with disruption of the interferon regulatory factor 3 gene (Irf3(-/-)), with or
113 etion of the downstream transcription factor interferon regulatory factor 3 resulted in reduced induc
114 f interferon genes - tank-binding kinase 1 - interferon regulatory factor 3) pathway, shedding light
115 1)-AKT (AKT serine/threonine kinase 1)-IRF3 (interferon regulatory factor 3) signaling cascade leadin
116 hatase 2A (PP2A) as a deactivator of phospho-interferon regulatory factor 3, the key transcription fa
120 on and decreased the nuclear accumulation of interferon regulatory factors 3 and 7 (IRF3 and -7) and
121 ase beta (IKKB), IkappaB kinase iota (IKKI), interferon regulatory factors 3 and 7, and rhinovirus in
123 articular, expression and phosphorylation of interferon-regulatory factor 3 (IRF3) was decreased in E
124 this study we have defined the mechanisms of interferon regulatory factor-3 (IRF-3) signaling in prim
125 increased PTEN/TLR4 (Toll-like receptor 4), interferon regulatory factor-3 (IRF3), nuclear factor ka
128 plex virus (HSV)-infected cells and initiate interferon regulatory factor-3 signaling, but it has bee
129 or B cell development and function, cellular interferon regulatory factor 4 (c-IRF4) directly regulat
134 es myeloid and B-cell leukemia by inhibiting interferon regulatory factor 4 (IRF4) but through distin
136 rtance of the oncogenic transcription factor interferon regulatory factor 4 (IRF4) in hematological m
144 d chemokine production, lung histopathology, interferon regulatory factor 4 (IRF4) mRNA expression, a
146 microbial products, the transcription factor interferon regulatory factor 4 (IRF4) promotes regulator
148 T) proteins and on the cooperative action of interferon regulatory factor 4 (IRF4) with activator pro
149 r Th17 skewing conditions and phosphorylates interferon regulatory factor 4 (IRF4), a transcription f
150 type is accompanied by a higher induction of interferon regulatory factor 4 (IRF4), a transcriptional
152 et is controlled by the transcription factor interferon regulatory factor 4 (IRF4), which is required
157 ated STAT3 and reduced protein expression of interferon regulatory factor 4 and B-cell lymphoma 6 (BC
158 n and small molecule inhibition downregulate interferon regulatory factor 4 and MYC, and provides an
160 of lenalidomide are associated with reduced interferon regulatory factor 4, a downstream target of c
161 hemistry for MYC, BCL2, CD10, BCL6, and MUM1/interferon regulatory factor 4, and fluorescent in situ
162 sion of CCAAT/enhancer-binding protein-beta, interferon regulatory factor 4, and peroxisome prolifera
163 cluding CCAAT/enhancer-binding protein-beta, interferon regulatory factor 4, and peroxisome prolifera
164 tion was found to be driven by 2 variants of interferon regulatory factor 4-dependent dermal type 2 c
175 Similar to Puma, the transcription factor interferon regulatory factor 5 (Irf5) has been reported
176 hether silencing of the transcription factor interferon regulatory factor 5 (IRF5) in cardiac macroph
181 f p53-mediated LMP1 expression, we find that interferon regulatory factor 5 (IRF5), a direct target o
182 4 kinase activity controls the activation of interferon regulatory factor 5 (IRF5), a transcription f
183 henotype due to decreased P-STAT1 (Y701) and interferon regulatory factor 5 compared with NOD mice.
184 Mechanistically, lack of IRAK4 resulted in interferon regulatory factor 5 homodimerization via redu
185 crosis factor-alpha, the chemokine CCL2, and interferon regulatory factor-5 (IRF5), a marker of infla
190 tor-interacting protein kinase 4 (RIPK4) and interferon regulatory factor 6 (IRF6) are critical regul
191 actor beta (TGFbeta) signaling molecules and interferon regulatory factor 6 (Irf6) have been identifi
193 ion of canonical WNT signaling perturbed p63/interferon regulatory factor 6 (p63/IRF6) signaling, res
195 N-lambda expression by hMPV was dependent on interferon regulatory factor 7 (IRF-7) expression but no
196 interferon regulatory factor 3 (IRF-3), and interferon regulatory factor 7 (IRF-7) were not required
197 otherwise enhanced amounts of the requisite interferon regulatory factor 7 (IRF-7), whose gene expre
198 C in LMP1 signaling leading to NF-kappaB and interferon regulatory factor 7 (IRF7) activation has not
199 f (RHIM) domains of TRIF and RIP1 to disrupt interferon regulatory factor 7 (IRF7) activity, a critic
200 lysine 48-linked polyubiquitination of both interferon regulatory factor 7 (IRF7) and IRF3 followed
201 m, while expression of transcription factors interferon regulatory factor 7 (IRF7) and IRF9, implicat
203 ly shown that ORF45 suppresses activation of interferon regulatory factor 7 (IRF7), a crucial regulat
205 nate antiviral immunity by downregulation of interferon regulatory factor 7 (IRF7), an immune factor
206 r MyD88, the downstream transcription factor interferon regulatory factor 7 (IRF7), and type I interf
207 paB)-dependent proinflammatory cytokines and interferon regulatory factor 7 (IRF7)-dependent type I i
208 roteins from human pDCs, pDC-cell lines, and interferon regulatory factor 7 (IRF7)-expressing B-cell
210 anistically, IL-33 downregulated viperin and interferon regulatory factor 7 gene expression and rapid
214 cated suppression of antiviral host factors (interferon regulatory factor 7, CXCL10 [gamma interferon
215 IRF7, which encodes the transcription factor interferon regulatory factor 7, in an otherwise healthy
216 ce of hyperconnected hub nodes, most notably interferon regulatory factor 7, which was identified as
217 cent epidemiological studies have identified interferon regulatory factor 8 (IRF8) as a susceptibilit
219 fied novel associations in the chromosome 16 interferon regulatory factor 8 (IRF8) gene (P-value = 2.
225 epressive effect of the transcription factor interferon regulatory factor 8 (IRF8), which is highly e
226 eded the genome-wide significance threshold: interferon regulatory factor 8 (IRF8; rs11644034; p(meta
227 de statistical significance within the IRF8 (interferon regulatory factor 8) gene (combined P values
230 y interferon regulatory factor-1 (IRF-1) and interferon regulatory factor-8 (IRF-8 or ICSBP), play im
232 rise from perturbations in the regulation of interferon regulatory factor-8 (IRF-8), an integral tran
234 feron-stimulated gene factor 3 [ISGF3]) with interferon regulatory factor 9 (IRF9) and translocate to
235 d activator of transcription (STAT) 1 and 2, interferon regulatory factor 9, N-myc and STAT interacto
238 ed that IRG1 is not an miR93 target but that interferon regulatory factor-9, which can regulate IRG1
239 were conducted to examine the role of miR93-interferon regulatory factor-9-immunoresponsive gene-1 (
240 ulator (NEMO), an essential adaptor bridging interferon-regulatory factor and NF-kappaB activation.
241 cally, we demonstrated that TRIM29 inhibited interferon-regulatory factors and signaling via the tran
242 iallelic mutations in IRF8, which encodes an interferon regulatory factor, as a cause of familial NK
243 ially regulated cell genes identified an ETS-interferon regulatory factor composite element motif tha
244 ent expression of DNA-dependent activator of interferon regulatory factors (DAI, also known as ZBP1 o
245 ceptor 9 (TLR-9), DNA-dependent activator of interferon-regulatory factors (DAI), and absent in melan
247 egulatory factor 4 (IRF4) is a member of the interferon regulatory factor family of transcription fac
249 gulators of type I and type III interferons, interferon regulatory factor (IRF) 3 and IRF7, were sign
250 kinase-1 (TBK1)-dependent phosphorylation of interferon regulatory factor (IRF) 3 and transcription o
253 e, using 6-week-old mice triply deficient in interferon regulatory factor (IRF) as a model, we show t
254 er of adipocyte inflammation, members of the interferon regulatory factor (IRF) family may also play
261 that secretes excess c-di-AMP activates the interferon regulatory factor (IRF) pathway with enhanced
263 ex pattern of deregulated TFs, we discovered interferon regulatory factor (IRF) sites among the top e
266 ctly targeting high mobility group box-1 and interferon regulatory factor (IRF)-5, preventing activat
267 iethylhexyl phthalate suppressed CpG-induced interferon regulatory factor (IRF)-7 expression by suppr
269 e shared genes showed sequences required for interferon regulatory factor (IRF)-mediated transcriptio
270 gnaling pathways and cause activation of the interferon regulatory factor (IRF-3) transcription facto
272 f transcription 1 [STAT1], protein kinase R, interferon regulatory factors (IRF) IRF-1, IRF-3, IRF-5,
273 of RANTES was regulated by NF-kappaB and the interferon regulatory factors (IRF)-1, IRF-3, and IRF-7
274 ng pathway (preserved STAT1 phosphorylation, interferon regulatory factor [IRF] nuclear translocation
277 of the PD-L1 transcriptional repressors, the interferon regulatory factors IRF2 and IRF2BP2, which li
278 with ELF4 increases the binding affinity of interferon regulatory factors IRF3 and IRF7, which is me
279 s the activation of the transcription factor interferon regulatory factor (IRF4), which, along with t
280 ron response that could be driven in part by interferon regulatory factors (IRFs) and increased NF-ka
281 ositive-feedback loops mediated by inducible interferon regulatory factors (IRFs) and retinoic acid i
285 ored in cells and mice deficient in specific interferon regulatory factors (IRFs) or the common type
288 y shown that three KSHV homologs of cellular interferon regulatory factors (IRFs), known as viral IRF
289 known to encode viral homologues to cellular interferon regulatory factors (IRFs), known as vIRFs.
290 eir expression of viral homologs of cellular interferon regulatory factors (IRFs), termed viral IRFs
291 at they express viral homologues to cellular interferon regulatory factors (IRFs), termed viral IRFs
292 und by BLIMP1 in vitro overlaps with that of interferon regulatory factors (IRFs), which respond to i
294 e, cyclooxygenase-2) and a MyD88-independent interferon regulatory factor-mediated pathway that regul
295 in melanoma 2 and DNA-dependent activator of interferon regulatory factor) opened a new paradigm: Nuc
299 ies, including beta-catenin, Ap-1, NFkappaB, interferon regulatory factors, STATs, JUN, and p53.
300 celerating factor; IKK, IkappaB kinase; IRF, interferon regulatory factors; TBK1, TANK-binding kinase
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。